Molecule Details
InChIKeyBHLXTPHDSZUFHR-UHFFFAOYSA-N
Compound NameVarespladib
Canonical SMILESCCc1c(C(=O)C(N)=O)c2c(OCC(=O)O)cccc2n1Cc1ccccc1
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)12
Pfam Stratification Cross-Family
Avg pChEMBL6.98
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB11909
Drug NameVarespladib
CAS Number172732-68-2
Groups investigational
ATC Codes nan
DescriptionVarespladib has been investigated for the treatment and prevention of Sickle Cell Disease, Vaso-occlusive Crisis, and Acute Coronary Syndrome.

Categories: Acids, Acyclic Fatty Acids Fatty Acids, Volatile Heterocyclic Compounds, Fused-Ring Lipids Phospholipase A2 Inhibitors Phospholipases A, antagonists & inhibitors
Cross-references: BindingDB: 50055366 CHEMBL148674 ChemSpider: 137248 PDB: VRD PubChem:155815 PubChem:347828241 Wikipedia: Varespladib ZINC: ZINC000001543773
Target Activities (12)
Target Gene Organism Category Pfam pChEMBL Type Source
P14555 PLA2G2A Homo sapiens Human PF00068 7.9 IC50 ChEMBL;BindingDB
Q9NZK7 PLA2G2E Homo sapiens Human PF00068 7.3 IC50 ChEMBL;BindingDB
O15496 PLA2G10 Homo sapiens Human PF00068 7.1 IC50 ChEMBL;BindingDB
Q9UNK4 PLA2G2D Homo sapiens Human PF00068 7.1 IC50 ChEMBL;BindingDB
Q5R387 PLA2G2C Homo sapiens Human PF00068 6.9 IC50 ChEMBL
Q9BX93 PLA2G12B Homo sapiens Human PF06951 6.9 IC50 ChEMBL;BindingDB
Q9BZM1 PLA2G12A Homo sapiens Human PF06951 6.9 IC50 ChEMBL
Q9NZ20 PLA2G3 Homo sapiens Human PF05826 6.9 IC50 ChEMBL
Q9BZM2 PLA2G2F Homo sapiens Human PF00068 6.9 IC50 ChEMBL;BindingDB
P04054 PLA2G1B Homo sapiens Human PF00068 6.6 IC50 ChEMBL;BindingDB
O60733 PLA2G6 Homo sapiens Human PF00023 PF12796 PF01734 6.6 IC50 ChEMBL;BindingDB
P39877 PLA2G5 Homo sapiens Human PF00068 6.6 IC50 ChEMBL;BindingDB
DrugBank Target Actions (1)
Target Gene Target Name Action Type
P04054 PLA2G1B Phospholipase A2 other/unknown targets